Bicara Therapeutics Inc. Common Stock
BCAX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$68 | -$52 | -$38 |
| Dep. & Amort. | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $7 | $2 | $1 |
| Change in WC | -$14 | -$10 | $5 |
| Other Non-Cash | -$0 | $14 | $0 |
| Operating Cash Flow | -$75 | -$46 | -$32 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$1 | -$0 |
| Financing Activities | – | – | – |
| Debt Repay. | $0 | $0 | $0 |
| Stock Issued | $332 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | $2 | $272 | $32 |
| Financing Cash Flow | $334 | $272 | $32 |
| Forex Effect | $0 | $0 | $0 |
| Net Chg. in Cash | $259 | $226 | -$1 |
| Supplemental Information | – | – | – |
| Beg. Cash | $230 | $4 | $5 |
| End Cash | $490 | $230 | $4 |
| Free Cash Flow | -$75 | -$46 | -$32 |